Log In
Print
BCIQ
Print
Print this Print this
 

GLP-1 agonist

  Manage Alerts
Collapse Summary General Information
Company Sosei Group Corp.
DescriptionOral once-daily glucagon-like peptide-1 (GLP-1) agonist
Molecular Target Glucagon-like peptide-1 receptor (GLP-1R) (GLP1R)
Mechanism of ActionGlucagon-like peptide-1 (GLP-1) receptor agonist
Therapeutic ModalityPeptide
Latest Stage of DevelopmentPreclinical
Standard IndicationDiabetes
Indication DetailsTreat Type II diabetes
Regulatory Designation

Partner


 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today